Seung-Bae Kim

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.

Eunkyoung Kim, Yoon-Koo Kang, Sang-We Kim, 2003, Journal of Korean medical science.

Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.

Sang‐wook Lee, S. Choi, S. Nam, 2006, International journal of radiation oncology, biology, physics.

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.

Eunkyoung Kim, Yoon-Koo Kang, Sang-We Kim, 2003, Journal of Korean medical science.